Approximately 10 million people suffer from Hepatitis C worldwide. Pharma companies all over the world have been investing time and money in research to arrive at therapies to effectively treat Hepatitis C. Drug firm Zydus Heptiza has been launched a generic version of Sofosbuvir in India under the brand name ‘SoviHep V’. This antiviral medication is a combination of two DAAs (direct-acting antiviral) drugs which are used to treat chronic hepatitis C virus infections. These drugs work by weakening the activity of proteins needed by hepatitis C.

One of the two drugs in Sovihep-V is Sofosbuvir, which is a nucleotide polymerase inhibitor, and the other is Velpatasvir, which is an NS5A (hepatitis C virus non-structural protein 5A) inhibitor. Sofosbuvir interferes with the reproduction of the genetic material of the hepatitis C virus. Velpatasvir works by interfering with a protein needed by the virus. Together these two drugs greatly reduce and then stop the production of new copies of hepatitis C viruses. Drugssquare proudly offers discounted hepatitis products, and carry a selection of over 15,000 items from hundreds of well-known brands in the industry. This is done to help ensure that our customers can find the solutions they need. In fact, we are known for our cutting-edge solutions to specific medical needs.

[b]About Drugssquare[/b]

Drugssquare is a leading provider of generic & branded pharmaceutical products serving all segments of the healthcare market including hospitals and clinics, nursing homes and long-term care facilities, private medical practices, therapists, and more. With the most comprehensive range of quality medicines and top brands available, we provide "one stops shopping" access to the best value and selection. We listen, dig and uncover insights while working alongside leading experts in the field. As a result, we provide tailored solutions to match the unique needs of our customers.

[b]Source:[/b] https://www.prlog.org/12648876-drugssquare-announces-addition-of-sovihep-combination-of-velpatasvir-and-sofosbuvir.html